Features
Get A Demo
Plans
Sign Up
Login
All Federal Grant Awards
Help
Project Grant HT94252310182
Award Date
3/1/23
Completion Date
2/28/25
Dollars Obligated
$550K
Overview
Activity
1
Transactions
3
Subawards
Federal Agency
Defense Health Agency
Awardee
Seal Rock Therapeutics, Inc. (P23WBJRKFLA1)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98101, USA
Description
Update #1
PRECLINICAL EVALUATION OF ASK1 INHIBITOR SRT 055 AS A POTENTIAL DEVELOPMENT CANDIDATE FOR ALS
Posted 2/28/23, 12:00 AM
Mod #
Description
Reason For Modification
Federal Obligation
(Click to sort descending)
Date
(Click to sort ascending)
Not listed
PRECLINICAL EVALUATION OF ASK1 INHIBITOR SRT-055 AS A POTENTIAL DEVELOPMENT CANDIDATE FOR ALS. EXTENDS THE POP BY 12 MONTHS.
$0
1/23/24
Not listed
PRECLINICAL EVALUATION OF ASK1 INHIBITOR SRT-055 AS A POTENTIAL DEVELOPMENT CANDIDATE FOR ALS ADD FUNDING IN ACCORDANCE WITH THE DIRECT COST RESTRICTION STATED IN THE PROGRAM ANNOUNCEMENT
$2.9k
9/25/23
Not listed
PRECLINICAL EVALUATION OF ASK1 INHIBITOR SRT 055 AS A POTENTIAL DEVELOPMENT CANDIDATE FOR ALS
$547.1k
2/28/23